Risk of infectious complications during anti-TNFalpha therapy
Branten, A.J.W.
Netherlands Journal of Medicine 66(2): 50-52
2008
ISSN/ISBN: 0300-2977 PMID: 18292606 Document Number: 616234
Document emailed within 1 workday
Related Documents
Dekker, L.; Armbrust, W.; Rademaker, C.M.A.; Prakken, B.; Kuis, W.; Wulffraat, N.M. 2004: Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis Clinical and Experimental Rheumatology 22(2): 252-258Dimitrov, O.; Dinov, P.; Martsenkova, K.; Khadzhiev, K.; Kolarov, G. 1989: Cesarean section and postoperative infectious-inflammatory complications. I. A new method for assessing the degree of risk of infectious-inflammatory complications Akusherstvo i Ginekologiia 28(6): 29-33
Ortonne, J.P. 2005: Therapeutic management of plaque psoriasis: the interest of anti-TNFalpha Annales de Dermatologie et de Venereologie 132(8-9 Pt 2: 4s6-4s9
Gomollón, F.; López, S.G.ía. 2008: Treatment with anti-TNFalpha agents in Crohn's disease: what drug we have to use and when? Acta Gastroenterologica Latinoamericana 38(2): 133-145
Tuveng, J.M.; Vold, I.; Jerve, F.; Eng, J.; Skaug, K.; Eyolfsson, O. 1985: Hysterosalpingography: value in estimating tubal function, and risk of infectious complications Acta Europaea Fertilitatis 16(2): 125-128
Karpova, E.P.; Tulupov, D.A. 2013: Local therapy of infectious complications of allergic rhinitis in the children Vestnik Otorinolaringologii 5: 73-76
Vĕsín, S.; Sulková, S. 1985: Infectious osseous complications in patients on chronic hemodialysis therapy Ceskoslovenska Radiologie 39(3): 173-180
D'Alessandria, C.; Malviya, G.; Viscido, A.; Aratari, A.; Maccioni, F.; Amato, A.; Scopinaro, F.; Caprilli, R.; Signore, A. 2007: Use of a 99mTc labeled anti-TNFalpha monoclonal antibody in Crohn's disease: in vitro and in vivo studies Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 51(4): 334-342
Wolska-Kuśnierz, B.; Kurenko-Deptuch, M.; Bernatowska, E. 2008: Difficulties in diagnostics and therapy of infectious complications in primary immunodeficient patients Przeglad Epidemiologiczny 62(1): 123-131
Reyad, A.; Waldron, C.; Canning, R.; O'Shea, D.; Coakley, P.; McConkey, S. 2009: An audit on virological efficacy of anti-retroviral therapy in a specialist infectious disease clinic Irish Medical Journal 102(6): 186-188
Skorliakov, A.V.; Bystrenin, M.A.; Voloshinova, E.V. 2007: The character and structure of infectious complications in patients with chronic renal failure, who received or did not receive replacement therapy (hemodialysis) Klinicheskaia Meditsina 85(10): 59-61
Wibaux, Cécile.; Andrei, I.; Paccou, J.; Philippe, P.; Biver, E.; Duquesnoy, B.; Flipo, Ré.Marc. 2010: Pregnancy during TNFalpha antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases Joint Bone Spine 77(3): 268-270
Iftikhar, R.; Chaudhry, Q.Un.Nisa.; Satti, T.Mehmood.; Mahmood, S.Kamran.; Satti, H.Shafique.; Ghafoor, T.; Khan, M.Ali. 2018: Noble Metal Coated Central Venous Catheters Are Not Superior To Uncoated Catheters In Preventing Infectious And Non-Infectious Complications In Immunocompromised Patients Journal of Ayub Medical College Abbottabad: Jamc 30(Suppl. 1)(4): S647-S651
Piérard, G.E.; Arrese, J.E.; Claessens, N.; Greimers, R.; Piérard-Franchimont, C.; Naeyaert, J.M. 1999: Bacterial resistance during anti-acne antibiotic therapy. how to limit the risk Revue Medicale de Liege 54(2): 100-104
den Broeder, A.A.; Creemers, M.C.W.; Fransen, J.; de Jong, E.; de Rooij, D-Jan.Ram.; Wymenga, A.; de Waal-Malefijt, M.; van den Hoogen, F.H.J. 2007: Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study Journal of Rheumatology 34(4): 689-695
Zarranz Imirizaldu, J.J. 1997: Anti-aggregation therapy for prevention of cerebral ischemic stroke: a risk benefit analysis Medicina Clinica 109(20): 802-807
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Konstantinov, V.O. 2017: The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications Kardiologiia 57(5): 68-72
Nakaie, N.; Tuon, S.; Nozaki, I.; Yamaguchi, F.; Sasaki, Y.; Kakimoto, K. 2014: Family planning practice and predictors of risk of inconsistent condom use among HIV-positive women on anti-retroviral therapy in Cambodia Bmc Public Health 14: 170
Smith, R.M.; Carrico, A.W.; Montandon, M.; Kwena, Z.; Bailey, R.; Bukusi, E.A.; Cohen, C.R. 2011: Attitudes and beliefs about anti-retroviral therapy are associated with high risk sexual behaviors among the general population of Kisumu, Kenya Aids Care 23(12): 1668-1675